Explore more publications!
Sci-Tech Reporter Solomon Islands
Submit Press Release

Sci-Tech Reporter Solomon Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Reporter Solomon Islands.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 3, 2025

Will Bitcoin Drop Below $100K? Volatility Is Unpredictable — AG META RWA Shows You How to Hedge Risks with Real Assets
November 3, 2025

Will Bitcoin Drop Below $100K? Volatility Is Unpredictable — AG META RWA Shows You How to Hedge Risks with Real Assets

Indeterminate GlobeNewswire
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
November 3, 2025

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Datavault AI, Music Dash and NFHITS Partner to Transform Music Data Tracking Display and Monetization Through Patented Inaudible Tones®, AI and Blockchain Technology
November 3, 2025

Datavault AI, Music Dash and NFHITS Partner to Transform Music Data Tracking Display and Monetization Through Patented Inaudible Tones®, AI and Blockchain Technology

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
November 3, 2025

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

Indeterminate GlobeNewswire
DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial
November 3, 2025

DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
November 3, 2025

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

Indeterminate GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
November 3, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025

Indeterminate GlobeNewswire
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 octobre 2025
November 3, 2025

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 octobre 2025

Indeterminate GlobeNewswire
CryptoMondays: Where Decentralized Minds Meet to Build the Future
November 3, 2025

CryptoMondays: Where Decentralized Minds Meet to Build the Future

Indeterminate GlobeNewswire
NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
November 3, 2025

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

Indeterminate GlobeNewswire
NANOBIOTIX participera à des conférences investisseurs la semaine du 10 novembre
November 3, 2025

NANOBIOTIX participera à des conférences investisseurs la semaine du 10 novembre

Indeterminate GlobeNewswire
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
November 3, 2025

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

Indeterminate GlobeNewswire
Regeneron Announces Investor Conference Presentations
November 3, 2025

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
November 3, 2025

Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call

Indeterminate GlobeNewswire
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
November 3, 2025

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Indeterminate GlobeNewswire
BBOT to Participate in the Jefferies Global Healthcare Conference in London
November 3, 2025

BBOT to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions